Fig. 1. The cytotoxic effects of galangin and myricetin on ovarian cancer cells A2780/CP70 and OVCAR-3.
(A) Galangin decreased cell viability in ovarian cancer cells. (B) Myricetin decreased cell viability in ovarian cancer cells. Cells (2×104 /well) were seeded in 96-well plates, incubated overnight, and then treated with galangin or myricetin for 24 h. Cell viability was determined by CellTiter 96 AQueous One Solution Cell Proliferation Assay and expressed as percentages of control. *p < 0.05 as compared to control.